Rheumatic Diseases Clinical Trial
Official title:
A Clinical Randomized Controlled RSA Trial Comparing the Cemented Attune (S+ Tibia Tray) Fixed Bearing Cruciate Retaining Knee System With the Cemented PFC Sigma Fixed Bearing Cruciate Retaining Knee System
The PFC Sigma Knee by DePuy Synthes is an excellent knee replacement with an excellent clinical track record, good survival rates (98% 10 years survival in patients aged < 55 years) and minimal early migration as measured with RSA (0.5mm MTPM at two years follow-up). The Attune Knee by DePuy Synthes is an advancement in knee replacement options. It is designed to provide better range of motion and address the unstable feeling some patients experience during everyday activities, such as stair descent and bending. To date, more than 470,000 patients have received an Attune Knee and positive feedback was received regarding patient recovery, stability and motion. The objective of this study is to accurately assess and compare migration, clinical and radiological outcome and patient reported outcomes of two knee prostheses: the Cemented Attune Fixed Bearing Cruciate Retaining Knee System and the Cemented PFC Sigma Fixed Bearing Cruciate Retaining Knee System, both by DePuy Synthes, Warsaw, Indiana, USA. The primary objective of this study is to compare the magnitude and pattern of migration of the prostheses (Femoral and Tibial component). The secondary objective of this study is to compare clinical and radiological outcome of the prostheses and PROMS. This study is designed as a single-blind, randomized trial between the Attune Knee System and PFC Sigma Knee System. 32 patients with the Attune Knee System and 32 patients with PFC Sigma Knee System will be included in this study. The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for knee replacement surgery at the Department of Orthopaedics, Haags Medisch Centrum The Hague (HMC), The Netherlands. Annually 350 TKA procedures are performed in this department, of which about 90% is Osteo Arthritis (OA) and 10% Rheumatoid Arthritis (RA) and other indications. We anticipate that inclusion can be accomplished within a 1 year period and that the total study duration is 3 years. Main study parameters/endpoints are: - Migration, measured by means of RSA. - Patient Reported Outcome Measures by means of questionnaires.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04976972 -
A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation
|
N/A | |
| Completed |
NCT04042792 -
Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
|
||
| Recruiting |
NCT05554029 -
Coronaphobia in Rheumatic Diseases
|
N/A | |
| Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
| Completed |
NCT02694796 -
Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy
|
N/A | |
| Completed |
NCT02269254 -
Persona Versus NexGen
|
N/A | |
| Completed |
NCT02256098 -
RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA
|
N/A | |
| Completed |
NCT00642837 -
A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets
|
Phase 4 | |
| Active, not recruiting |
NCT04704544 -
Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)
|
N/A | |
| Completed |
NCT05026853 -
Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice
|
N/A | |
| Active, not recruiting |
NCT04631965 -
Healthcare Transition of Adolescents With Chronic Health Conditions
|
||
| Recruiting |
NCT00024479 -
Natural History of Rheumatic Diseases in Minority Communities
|
||
| Completed |
NCT05031104 -
Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis
|
N/A | |
| Not yet recruiting |
NCT04567576 -
Predictive Factors for COVID-19 in Rheumatology
|
||
| Completed |
NCT02291471 -
Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers
|
Phase 1 | |
| Completed |
NCT01227694 -
Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01071447 -
Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment
|
N/A | |
| Active, not recruiting |
NCT05618782 -
Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
|
Phase 2 | |
| Active, not recruiting |
NCT05543642 -
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
|
Phase 4 | |
| Active, not recruiting |
NCT02694185 -
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
|
N/A |